Rat cDNAs encoding neuronal isoforms of protein phosphatase 1 (PPl) were isolated and their primary structures elucidated.
The derived amino acid sequences allowed us to design synthetic C-terminal peptides that were used to raise antibodies.
Isoform-specific anti-peptide antibodies against PPla and PPlyl were used to investigate the tissue distribution of PPl isoforms by immunoblotting. Both isoforms were ubiquitously expressed in mammalian tissues, with the highest levels being observed in brain. Of all neuronal tissues examined, PPlol and PPlyl were found to be most abundantly expressed in the striatum. Lesion experiments with kainic acid indicated that both the (Y and the yl isoforms of protein phosphatase 1 were relatively enriched in the medium-size spiny neurons of the striatum.
"In situ" hybridization to rat brain slices using highly sensitive riboprobes also showed PPl (Y, PPl p, and PPlyl to be widely expressed in mammalian brain. However, some interesting differences were observed. For example, PPla and PPlyl were found to be expressed in the striatum, where DARPP-32 (dopamineand CAMP-regulated phosphoprotein, M, = 32,000 Da) is also known to be highly expressed.
PPlp appeared to be relatively less abundant in the same cells, as judged both by "in situ" hybridization and by the apparent absence of PPl p clones from the striatal cDNA libraries used. in situ, kainic acid, phosphatase, PP1, striatum] The balance between protein kinase and phosphatase activities in eukaryotic cells is responsible for controlling levels of protein phosphorylation, and is thought to be the major regulatory mechanism governing a variety of cellular processes (Nestler and Greengard, 1984; Hunter, 1987) . Indeed, it is likely to be of particular importance in mammalian brain since kinases and phosphatases are particularly abundant in this tissue (Nairn et Recei ved May 25, 1994; revised Oct. I I. 1994; accepted Oct. 3 I, 1994 Shenolikar and Nairn, 1991) . The family of serine/ threonine-specific protein phosphatases was originally divided into four groups (types I, 2A, 2B, and 2C), according to substrate specificity and metal ion dependence ). However, recent work has indicated that whereas phosphatases type I, 2A, and 2B are highly homologous members of the same family (Berndt et al., 1987; Shenolikar and Nairn, 1991) , phosphatase 2C seems to belong to an unrelated family (Tamura et al., 1989) . PPI (protein phosphatase I) is known to be widely distributed in mammalian tissues and to have a broad substrate specificity ilz vitro. It is thought to be regulated in viva by its interaction with regulatory and inhibitory proteins (Shenolikar and Nairn, 1991) . These proteins can be phosphorylated/dephosphorylated in response to extracellular stimuli and thus dynamically regulate the activity of PPI.
At least three different heat-stable inhibitor phosphoproteins of protein phosphatase I are known to exist in mammalian cells [inhibitor I, inhibitor 2, and DARPP-32 (dopamine-and CAMPregulated phosphoprotein, M, = 32,000 Da)]. Inhibitor 1 and DARPP-32 share many biochemical similarities, including primary structure homology, heat and acid stability, and the ability to potently inhibit PPI following phosphorylation by CAMPdependent protein kinase (Hemmings et al., 1984a,b; Williams et al., 1986) . Although structurally and functionally related, inhibitor I and DARPP-32 exhibit different patterns of expression. Whereas inhibitor I is ubiquitously expressed in a variety of mammalian tissues, DARPP-32 expression is relatively restricted, being most abundant in the medium-sized spiny neurons of the striatum. Furthermore, recent studies indicate that both are relatively enriched in striatal neurons and striatonigral fibers (Nairn et al., 1988) . Given the central role of reversible protein phosphorylation in the control of neuronal function, it is important to determine the distribution of protein phosphatases in mammalian brain. In the present study we have investigated the distribution of various isoforms of protein phosphatase I in the brain.
Some of the data presented here was the subject of a preliminary report (da Cruz e Silva and Greengard, 1992 SI  IGRLLEVQ  GSRPGKNVQL   177  ACAGAGAACGAGATCCGTGGTCTTTGCCTC  AAATCCCGGGAGATTTTCCTGAGCCAGCCT  ATTCTTCTGGAGCTTGAGGCGCCTCTCAAG  31  T  EN  E IRGLCL  KSREIFLSQP  ILLELEAPLK   267  ATCTGTGGTGACATCCATGGCCAGTACTAT  GACCTTCTACGGCTGTTCGAGTATGGTGGC  TTCCCTCCAGAGAGCAACTACCTCTTCTTG  61  I  CGDIHGQYY  DLLRLFEYGG  FPPESNYLFL   357  GGGGACTATGTGGATCGGGGCAAGCAGTCT  TTGGAGACCATCTGCTTGTTGCTGGCCTAT  AAGATCAAATACCCGGAGAATTTTCTTTCTA  91  GDYVDRGKQS  LETICLLLAY  KIKYPENFFL   447  CTACGTGGGAACCATGAGTGTGCCAGCATC  AACCGCATCTATGGCTTCTATGATGAATGC  AAGAGACGATACAACATCAAACTGTGGAAG  121  L R GN  H ECASI  NRI  YGFYDEC  KRRYNI  K L W K   537  ACTTTCACCGACTGCTTCAACTGCCTGCCC  ATTGCAGCCATTGTAGATGAGAAGATCTTC  TGCTGCCACGGAGGCCTGTCTCCAGACTTG  151  TFTDCFNCLP  IAAIVDEKIF  CCHGGL  S P D L   627  CAATCCATGGAGCAGATTAGACGTATTATG  CGGCCCACGGACGTGCCTGACCAGGGCCTG  TTGTGTGATCTGCTGTGGTCTGACCCTGAC  181  QSMEQIRRIM  RPTDVPDQGL  LCDLLWSDPD   717  AAGGATGTTCAAGGCTGGGGCGAGAATGAC  CGTGGAGTCTCCTTTACCTTTGGGGCCGAG  GTTGTAGCCAAGTTCCTGCACAAGCATGAT Figure 2 . A, Diagrammatic representation of the mRNA encoding rat PPI y 1. The coding region is identified with horizontal hrrrs. Partial cDNAs used to derive the cDNA sequence are aligned below. The WMWS indicate the fragment used to generate riboprobes for in .situ hybridization. H, Partial nucleotide and deduced amino acid sequence of rat striatum PPlyl. purification column (Stratagene, La Jolla, CA). The probe used conof the A gt IO vector (FPIO = 5'-TTG AGC AAG TTC AGC CTG sisted of the full length rabbit PPIo cDNA (Bai et al., 1988) . Pos-GTT AAG-3' and RPIO = 5'.GCT TAT GAG TAT TTC TTC CAG itive clones were purifed by successive replating. Single well-iso-GGT-3'). Reaction conditions consisted of 5 min at 94°C followed lated positive plaques were picked into 100 (*I of X diluent [IO mM by 30 cycles of I min denaturation at 94°C 2 min annealing at 65°C Tris-HC1 (pH 7.5)/10 mM MgSO,] and the phage allowed to diffuse and 3 min extension at 72°C and a final incubation at 72°C for IO out overnight at 4°C. The cDNA inserts were recovered by DNA min. Insert sizes were verified by agarose gel electrophoresis of the amplification using 5 pl of phage solution in a 100 pl reaction mixpolymerase chain reaction products. Figure 3 . A, Diagrammatic representation of the mRNA encoding rat PPIP. The coding region is identified with horizonrul bars. Partial cDNAs used to derive the cDNA sequence are aligned below (pRC1/2 was not sequenced in its entirety as indicated by the open box). The arrows indicate the fragment used to generate riboprobes for in situ hybridization. B, Nucleotide and deduced amino acid sequence of rat cortex PPlp.
otherwise, they were first digested with EcoRI and then ligated with EcoRI-digested pBluescript-KS'. An Okayama-Berg rat brain cortex cDNA library was screened for PPly using a partial cDNA for PPlyl obtained from the rat striatum library described above (pR9/3 in Fig. 2 ). For sequencing and further manipulations, the positive cDNAs were excised from the pCD vector using the restriction enzyme BamHI and ligated into the same site of pBluescript-KS'.
In order to obtain PPlp cDNA clones, a rat brain cortex cDNA library in X ZAP II was obtained from Stratagene (La Jolla, CA). Screening was performed in duplicate using PPI P-specific oligonucleotides (Sasaki et al., 1990) directed to either 5' or 3' untranslated region sequences (BETA-N = 5'-ATC TTG TAG GCA CCA GAC TCT CCT CCC CGC AGC-3' and BETA-C = 5'.AGG GTG TCG AAT GGC TGG ATG GTT TTA CAG TGC-3'). Oligonucleotides were labeled as follows: 40 pmol of either oligonucleotide was incubated for 30 min at 37°C in 50 )*I of 60 mM Tris-HCI (pH 7.8)/10 mM MgC&/14 mM p-mercaptoethanol containing 120 FCi of y-I'P-ATP and 20 U of T4 polynucleotide kinase. These conditions resulted in virtually stoichiometric incorporation of label into the oligonucleotides, as determined by chromatography on Sephadex G-25 and polyacrylamide gel electrophoresis, and the probes were used without further purification. Prehybridization and hybridization were performed at 42°C in a buffer consisting of 90 mM Tris-HCI (oH 7.4YO.9 M NaCV6 mM EDTA/O.S% (v/v) Nonidet P40/2X Denhaydt's sohrtion/0.2% (w/v) SDS/O.OS% (w/v) sodium pyrophosphate/70 pg/ml E. coli tRNA/lOO pg/ml denatured salmon sperm DNA. Hybridization was carried out with 0.8 pmol ??P-labeled oligonucleotide/ml for 12-20 hr. Positive clones were identified, purified by successive replating and their cDNA inserts recovered by in vivo excision into pBluescript-SK-.
DNA sequencing. Double stranded plasmid DNA purified on Magic Miniprep columns (Promega Corporation, Madison, WI) was sequenced in the presence of 7-deaza-2'-ddTP (Sanger et al., 1977; Mizusawa et al.. 1986) . Plasmid DNA (l-2 ug) was denatured in 0.2 M NaOW0.2 mM EDTA for 5 min at room temperature, neutralized with 0.1 vol of 2 M ammonium acetate (pH 4.8) and precipitated with 2.5 vol of 100% ethanol. DNA was recovered by centrifugation, rinsed with 75% ethanol, dried under vacuum, and used for sequencing with Sequenase (United States Biochemicals, Cleveland, OH) under the manufacturer's recommended conditions. The sequencing primers used consisted of either pBluescript-specific or cDNA-specific oligonucleotides.
In situ hybridization. Adult male Sprague-Dawley rats (Charles River Laboratories, 250 gm) were sacrificed by decapitation. Their brains were rapidly removed, frozen in liquid isopentane (-30°C) for 30 set and stored at -80°C until sectioning. Frozen tissue blocks were warmed to -20°C and mounted on a chuck with M-l mounting medium (Lipshaw). Serial coronal sections (10 pm) were prepared using a Bright cryostat, thaw mounted (two sections per slide) onto polylysine subbed microscope slides and stored at -80°C.
Adjacent sections were processed for PPla, PPl B. or PPl yl in situ hybridization. Sections were removed from storage, fixed in 4% (w/v) formaldehyde for 60 min at room temperature and then rinsed three times in 2X SSC [300 mM NaCV30 mM Na citrate (pH 7.2)]. Sections were treated with proteinase K [ 1 pg/ml in 100 mM Tris-HC1 (pH 8.0)/ 50 mM EDTA] for IO min at 37"C, rinsed in water and treated with a mixture of 0.1 M triethanolamine (pH 8.0) and acetic anhydride (400: 1, V/V) with stirring for IO min. The sections were rinsed in 2X SSC, dehydrated through graded alcohols, and allowed to air dry. Serial brain sections were hybridized with ?'S-UTP-labeled riboprobes specific for each of the isoforms of protein phosphatase I. For this purpose, the following cDNA fragments were subcloned into pBluescript: (1) PPla, a 478 nt PstI fragment from pR14/1 (Fig. 1A) ; i2) PPlyi, a 377 nt EcoRI fragment from pR9/3 (Fig. 2A) ; (3)-PPIB, a 423 nt EcoRI fragment from oRC8/1 (Fig. 3A) .
Sense and antiseise cRNA probes were-generated by in vitro transcription of the linearized constructs, diluted in hybridization buffer [75% (v/v) formamide/lO% (w/v) dextran sulfate13X SSC/50 mM Na,PO, (pH 7.4)/l X Denhardt's/O.l mg/ml yeast tRNA/lO mM dithiothreitol] and applied to the sections to a final concentration of l-2 X 1Oh dpm/30 p,l. Thirty microliters of the hybridization solution were used per slide (containing two coronal sections), a coverslip was placed on top and the sections were hybridized overnight at 55°C in a humid chamber.
After hybridization, the sections were rinsed three times in 2X SSC, treated with RNase A [200 &ml in 100 mM Tris-HCI (pH 8.0)/0.5 M NaCl] for 1 hr at 37°C and rinsed again in 2X SSC. The-sections were then washed at room temoerature in 1 X SSC for 5 min. 0.5X SSC for 5 min, and 0. I X SSC for 5 min. Finally, the sections were washed in 0.1 X SSC at 65°C for 1 hr, rinsed in water at room temperature, dehydrated through graded alcohols, and air dried. The sections were then exposed to Kodak XAR-5 x-ray film for 8 d. Afterwards the sections were counterstained with cresyl violet.
The specificity of the in situ hybridization signal was verified using two sets of controls for each protein phosphatase clone. One set was used for RNase controls as follows. The sections were treated prior to hybridization with RNase A (200 pg/ml) for 1 hr at 37°C. before the proteinase K treatment. The control sections were then processed as described above and hybridized with either the PPla, PPl B, or PPlyl cRNA probes. No specific signal was observed on RNase A pretreated sections. The other set was processed for sense probe controls. Tissue sections were processed for in situ hybridization as described above. However, sense cRNA probes with sequences identical to the PPI mRNA sequences targeted by the antisense riboprobes were used. No specific signal was observed on sections hybridized with these sense strand probes.
Synthesis ofpeptides.
Synthetic peptides corresponding to C-terminal sequences for the (Y and the yl isoforms were synthesized at the Keck Foundation Biopolymer Facility (Yale University), and the PPlB peptide was synthesized at the Rockefeller University Protein Sequencing Facility. All peptides, purified by reverse-phase HPLC to >95% purity, yielded the expected amino acid composition and mass spectra (data not shown).
Conjugation of peprides und production of antibodies.
The purified peptides were conjugated to bovine thyroglobulin at a peptide:carrier ratio of 25: I. Thyroglobulin (33 mg) was dissolved in 2 ml of 0.125 M sodium phosphate buffer (pH 7.5) and filtered through a 0.22 pm Millex GV syringe filter. Peptide (1.25 pmol) dissolved in water was added directly to the thyroglobulin and the solution was allowed to cool to 4°C. Conjugation was initiated with the dropwise addition, over 20 min, of 2.5 ml of freshly diluted glutaraldehyde, and the reaction was allowed to proceed for a total of 2 hr at 4°C with constant stirring. The reaction was quenched with I50 pl of sodium borohydride (12.5 mglml) and stirred for a further 30 min at 4°C. Finally, the solution was dialyzed overnight against PBS (137 mM NaCl15.4 mM Na>HP0,/2.7 mM KCI/ I .8 mM KH,PO,, pH 7.4), aliquoted, and stored at -70°C until needed for immunization.
Antisera against PPl isoforms were obtained by injecting New Zealand White female rabbits intradermally at multiple sites with the conjugated peptides mixed with complete Freund's adjuvant. Initially, three rabbits were injected with each conjugated peptide. Each rabbit was then boosted on day 14 and day 21 with conjugated peptide mixed with incomplete Freunds adjuvant. Test bleeds were performed on day 28. The titer and specificity of this and subsequent weekly bleeds was assessed by immunoblotting against striatal homogenates and peptide dot blots. The sera showing the highest titer and specificity were chosen for affinity purification and further characterization.
Peptide affinity columns were prepared using the same peptides that were used to raise antibodies. The peptides were coupled to activated CH-Sepharose 4B under the manufacturer's recommended conditions and packed into a 5 ml column. The serum was liltered through 0.22 pm Millex-GV tilters and protease inhibitors were added to the following final concentrations: 25 mM benzamidine, 5 mM EDTA, I mM EGTA, 100 pM PMSF, 20 pg/ml leupeptin, 20 p,g/ml antipain, 5 kg/ ml pepstatin, 5 kg/ml chymostatin. Each sample was then applied to its respective affinity column and the flowthrough was reapplied to the column. After washing to ensure the removal of nonspecific IgG, specific antibodies were eluted with 4.3 M MgCl, and dialyzed against PBS overnight. Antibody solutions were concentrated by Centriprep (Amicon, Beverly, MA) centrifugation and their concentration was calculated from the absorbance at 280 nm, assuming a 1 mglml IgG solution to have an absorbance of I .4. The specificity of the affinity purified antibodies was checked by immunoblotting against recombinant PPI isoforms produced in insect Sf9 cells infected with the appropriate baculovirus (E. E da Cruz e Silva and I? Greengard, unpublished observations). Aliquots were stored at -70°C.
Immunoblotring.
Young adult male Sprague-Dawley rats were sacrificed by CO! asphyxiation and various brain and peripheral tissues were rapidly drssected on ice. Tissue samples were frozen immediately on dry ice. Boiling 1% (w/v) SDS was added and the samples homogenized by sonication. Insoluble material was removed by centrifugation at 12,000 X g for 5 min, and the protein concentration of the supernatants measured by the bicinchoninic acid method (Pierce, Rockford, IL) as described by Smith et al. (1985) . Aliquots were separated on 12% SDS-PAGE gels and transferred electrophoretically onto 0.2 pm pore size nitrocellulose membranes (Schleicher and Schuell, Keene, NH) at 200 mA for 12-16 hr in 20 mM Tris-HCI (pH 8.6)/150 mM glycine, containing 20% (v/v) methanol (Towbin et al., 1979) . Following transfer, nonspecific binding sites on the membranes were quenched at room temperature for I hr in TBS [50 mM Tris-HCI (pH 7.6)/150 mM NaCI/O.OS% (w/v) sodium azide)/Tween [TBSTTween = TBS + 0.05% (v/v) Tween 201 containing 2% (w/v) Carnation dried milk. Membranes were incubated in the same solution containing antiserum at the appropriate dilution for l-2 hr at room temperature. The membranes were washed 3 X 10 min with TBS/Tween and the bound antibodies were detected by radiolabeling with "'I-protein A, diluted IOOO-fold in TBS/Tween + 2% (w/v) milk. Finally, the blots were washed at room temperature 4 X IO min with TBSiTween, 2 X 5 min with TBS, dried and exposed at -70°C to Kodak X-Omat AR film using Du Pont Lighting Plus intensifying screens. For quantitative purposes, a PhosphoImager was used (Molecular Dynamics, Sunnyvale, CA).
Kainic acid lesion experiments.
Male Sprague-Dawley rats (150-200 gm) were anesthetized with 400 mgikg (i.p.) chloral hydrate, and kainic acid lesions were performed as previously described (Walaas and Greengard, 1984) . The right caudate-putamen (neostriatum) was infused with 1 pl of kainic acid (1 pg/pl in PBS) at a rate of 0.5 pl/min, using stereotactic coordinates derived from Konig and Klippel (I 963).
The animals were sacrificed 8-l 1 d postsurgery, and the striatum and substantia nigra were dissected from both sides of the brain and frozen immediately on dry ice. Homogenates were prepared immediately by sonication in boiling 1% (w/v) SDS and protein quantitation was performed by the bicinchoninic acid method (Smith et al., 1985) . Samples were then analyzed by SDS-PAGE followed by immunolabeling with the PPI isoform-specific antibodies as described above. As controls, duplicate samples were analyzed using anti-DARPP-32, anti-GFAP anti-actin. and anti-tubulin antibodies.
Results

Cloning of neuronal isoforms of rat PPI
Low stringency screening of a rat A gtl0 striatal cDNA library yielded a large number of positive clones. Sequence analysis revealed that they all encoded partial sequences derived either from PPla or PPlyl (see Discussion). Figure 1 shows the deduced full length sequence of rat PPlo( derived from a number of overlapping clones. In this initial screen a cDNA clone partially encoding PPlyl was isolated (pR9/3) and used to screen a rat cortex Okayama-Berg cDNA library, thought to be more likely to contain full length clones. Although two different clones were isolated from this library, sequence analysis indicated that they too were not full length. Figure 2 shows the partial sequence obtained for rat PPlyl from the various overlapping cDNAs. Since no PPlp clones were identified in either of the previous libraries, a rat cortex cDNA library in X ZAP II was subsequently screened using oligonucleotides whose sequences were derived from the rat liver PPlp cDNA sequence published by Sasaki et al. (1990) . The full length sequence of rat cortex PPlp derived from overlapping clones is shown in Figure 3 . The cDNA and deduced amino acid sequences of rat brain PPla, PPlp, and PPlyl were found to be identical to those reported by Sasaki et al. (1990) for rat liver.
In situ hybridization
The three PPl cRNA probes used for in situ hybridization were similar in size (377478 nucleotides) and were labeled to similar levels of specific activity. Therefore, the differences observed in signal intensity and distribution suggest that each PPl isoform has a relatively unique distribution in the rat brain (Figs. 4-8) .
Telencephalon. PPla, PPl l3, and PPl y 1 mRNAs were found in several olfactory structures, including the olfactory bulb, olfactory tubercle (Tu), anterior olfactory nucleus (AO), piriform cortex (PO), and nucleus of the lateral olfactory tract (Figs. 4,  5) . Although all three isoforms were found in these regions, PPlyl was most abundant followed by PPlp and then PPla. PPlyl seemed to be uniquely expressed in the islands of Calleja (ICj), whereas PPla and PPl l3 were largely absent. PPl mRNA was also abundant in the striatum, with PPla and PPlyl being the two predominant isoforms in the caudate-putamen (CPU) and the nucleus accumbens (Acb, Fig. 5 ). The globus pallidus, which is a major target of striatal efferents, was virtually devoid of PPla and PPl y 1 mRNA and contained only a small amount of PPlp mRNA. Overall, the highest levels of PPl mRNA in rat brain were found in the hippocampus. All three PPl isoforms were abundant in the four CA subfields as well as the dentate gyrus (DG; Figs. 6, 7). All three isoforms of PPl were expressed in nuclei of the amygdaloid complex (AMY), but the messenger RNAs encoding PPlp and PPlyl were expressed to a higher (C) mRNA.
Autoradiographic images of coronal slices through the rostra1 forebrain showing in siru hybridization of PPla (A) PPl p (B) and PPl yl
PPla mRNA generally had a lower level of signal at this level, but was moderately expressed in the anterior oifactory nucleus (A@, olfactory tubercle (Tu), and primary olfactory cortex (PO). PPI p mRNA had a high level of expression in the PO, but a lower level of expression in the Tu. 111 situ hybridization for PPlyl mRNA produced the highest level of signal, specifically in the Tu, PO, and AO. PPlo, PPlp and PPlyl mRNAs were found dispersed throughout layers 2-6 of the cerebral cortex at all levels examined. Auroraalograpntc Images Ot coronal sections through the forebrain at the level of the mid striatum showing in situ hybridization of PPlo (A), PPlP (B), and PPlyl (C) mRNA. PPlu mRNA was expressed in the caudate-putamen (CPU), diagonal band of Broca (DB), primary olfactory cortex (PO) and olfactory tubercle (Tu). PPIP mRNA was expressed distinctly in the DB, PO, and Tu, including low levels in the islands Of Calleja ([Cj), but only tow levels were observed in the CPU. PPlyl mRNA was found in the CPu, PO, Tu, and ICj, Figure 6 . Autoradiographic images of coronal sections through the forebrain at the level of the mid hypothalamus showing i n situ hybridization of PPla (A), PPl S (B), and PPl yl (C) mRNA. PPlu, PPI S, and PPI yl mRNAs were expressed at high levels in all hippocampal subregions (CA fields l-4 of Ammon's horn, CA; dentate gyms, DC). PPIS and PPlyl mRNAs were both distributed throughout the thalamus. The amygdaloid complex (AMY) contained low to moderate amounts of PPla, PPlS, and PPlyl mRNA. All three isoforms were only expressed at low levels in the hypothalamus. , and PPI yl (C) mRNA. PPla, PPI S, and PPI yl mRNAs were present in the dorsal raphe (DR) and hippocampus, which is mostly dentate gyrus in this plane of section. PPla, and especially PPlyl mRNA, showed robust expression in the pineal gland (P). All three PPI isoforms were localized in the central gray (CC) and PPlyl was also found in the pontine nuclei (Pn). degree than PPlcx mRNA (Fig. 6 ). In addition, the amygdalohippocampal transition area expressed high levels of all three PPI mRNAs. PPla mRNA was found throughout the bed nucleus of the stria terminalis, PPlyl mRNA was expressed to a lesser degree and PPI p mRNA was localized only in the ventral division of this nuclear complex (data not shown). PPlol, PPIP, and PPI yl mRNA were detected in layers 2-6 of the cerebral cortex at all levels of the rat brain (Cg, Fr, Par; . There was little evidence for PPI mRNA expression in a specific cortical layer, except in allocortical regions such as the piriform and hippocampal cortex, which are dominated by a single dense cell layer. The septum expressed moderate amounts of PPla and PPlyl mRNA, and the diagonal band of Broca (DB, Fig. 5 ) contained moderate amounts of all three PPI mRNAs (vertical and horizontal limbs).
Diencephulon. In general, the thalamus contained relatively high levels of PPl p and PPIyl mRNAs, but only low levels of PPIcK (Fig. 6) . PPlol mRNA was found mainly in medial and midline nuclei. The medial habenula (MHb) was the only region of the thalamus that expressed high levels of PPlu. PPIP mRNA labeling was more widespread in the thalamus, with particularly high levels of expression in the zona incerta and MHb. PPlyl mRNA, like PPl p, exhibited a wide thalamic distribution, but it was conspicuously abundant in the medial geniculate body and the MHb (not shown). The subthalamic nucleus (STh) contained all three PPI mRNAs (Fig. 6) . In general, the preoptic area and hypothalamus contained moderate amounts of PPla and PPI p mRNA, and a low amount of PPI y I mRNA (Fig. 6) . Hypothalamic nuclei expressing all three PPI isoforms include the suprachiasmatic nucleus, supraoptic nucleus, paraventricular nucleus, ventromedial nucleus, and the arcuate nucleus.
Mesencephulnn. The midbrain dopaminergic nuclei, the substantia nigra and ventral tegmental area, showed a distinctive distribution of PPI mRNA (not shown). PPla and PPlp mRNAs were localized in the substantia nigra, pars compacta and lower amounts were detected in the ventral tegmental area. No PPla or PPIP mRNA expression was observed in the substantia nigra, pars reticulata. PPlyl mRNA was also found within the ventral tegmental area, and within both the substantia nigra, pars reticulata and compacta. In addition to the midbrain dopaminergic nuclei, PPlyl mRNA was expressed at high levels in the red nucleus and the oculomotor nucleus, and at moderate levels in the interpeduncular nucleus. Both PPl p and PPI yl mRNAs were detected in the central gray (CG, Fig. 7) . The pineal gland (P) exhibited robust expression of PPlu and particularly PPlyl (Fig. 7) . However, a relatively low level of PPI p was detected in the pineal gland. PPlyl mRNA was also detected in the pontine nuclei (Pn, Fig. 7) . Rhombencephalon. Only a low level of PPlol mRNA was observed in pons and medulla. In contrast, PPlp and PPlyl mRNAs were broadly distributed in the pons and medulla. Higher than background levels of expression of PPl p and PPI y I mRNAs were detected in several cell groups, including the locus coeruleus (LC, Fig. 8 ) which is a primary source of noradrenergic neurons in the brain, the trigeminal nuclear complex (5, Fig. 8) , and the raphe nuclei, including the dorsal (DR, Fig. 7 ) and median raphe (data not shown), which are two major sources of serotonergic neurons. PPla was also localized to the dorsal (Fig. 7) and median raphe. In addition, PPlyl mRNA was localized in the vestibular nuclear complex. More caudally in the brainstem, PPI p and PPI yl mRNA were localized in the nucleus of the trapezoid body (Tz), the lateral reticular nucleus and A)
the inferior olivary complex. PPlB mRNA was expressed at an exceptional level in a few other brainstem nuclei, including the area postrema and the hypoglossal nucleus (data not shown). The cerebellum is probably the second richest brain structure in PPl mRNA, after the hippocampus. All three PPl mRNAs were found to be very abundant in the granular layer of the cerebellum (Gr, Fig. 8 ). In addition, the molecular layer of the cerebellum contained low amounts of PPlyl mRNA. PPla and PPlB were not detected in the molecular layer.
Choroid plexus. PPla, PPlB, and PPlyl mRNAs were all expressed in the choroid plexus of the rat brain (data not shown), which is also known to express relatively high levels of both DARPP-32 and inhibitor 1.
Production of isoform-speci$c antibodies
The availability of the deduced amino acid sequences for the three isoforms of PPl allowed us to design isoform-specific peptides. Given the high degree of identity between PPlo, PPlB and PPl yl, their C-terminal regions were chosen since they exhibited the greatest divergence. Figure 9A shows the alignment of their deduced C-terminal sequences, and highlights the peptides chosen for antibody production. Preliminary experiments identified RU34 and RU31 as the sera showing the highest titer and specificity against PPla and PPl y 1, respectively (data not shown). They were then purified by peptide affinity chromatography. The isoform specificity of the affinity purified antibodies is demonstrated in Figure 9B . Both RU34 (anti-PPla) and RU31 (anti-PPlyl) reacted specifically and strongly against the isoform to which they were raised and showed essentially no crossreactivity against the other isoform. RU31 (anti-PPly) was found to cross-react with a protein present in infected Sf9 cells but not in uninfected cells and, therefore, likely to be encoded in the baculovirus genome. This antibody failed to cross-react with any other mammalian protein (see Fig. 1 l) , raising the possibility of the existence of a baculoviral phosphatase related to PPl.
RU34 (anti-PPI a)
RU31 (anti-PPlyl)
Whereas it was relatively simple to obtain antibodies specific for PPla and PPl?/l, we were unable to obtain PPlB-specific antibodies using the peptide described and identical methodol-WY.
Immunoblot analysis of PPI expression
The availability of isoform-specific antibodies allowed an investigation of the expression of PPl isoforms in different brain regions and non-neuronal tissues by immunoblotting. Previous studies of neuronal PPl were mainly concerned with measurement of enzyme activity Nairn et al., 1988) , which is not a good indicator of protein abundance and fails to address the existence of different, closely related isoforms. Both antibodies identified a single protein of approximately 37 kDa as predicted from the deduced amino acid sequence (Figs. 10, 11 ). PPla and PPlyl were found to be expressed in all brain areas analyzed, with the highest levels of expression being observed in the striatum (Figs. 10-12 ). The isoform distribution was similar in the various regions tested, with three notable exceptions. PPl y 1 was relatively more abundant than PPlu in the olfactory bulb, olfactory tubercle and pineal gland. RU34 (anti-PPla) and RU31 (anti-PPly) also detected 37 kDa proteins in all non-neuronal tissues examined (Figs. 10, 11 ). In general, PPlu and PPlyl abundance was lower in non-neuronal tissues than in brain (Figs. 10-12) . Of all nonneuronal tissues analyzed, PPla and PPl y 1 showed the highest levels of expression in thymus, kidney, spleen, and intestine (Fig. 12) . Interestingly, RU34 (anti-PPla) identified an additional protein of about 30 kDa in rat kidney (Fig. 10) . The expression of this protein of aberrant molecular mass is restricted to renal cortex, being largely absent from the medulla (D. Li, G. Celsi, E. E da Cruz e Silva, P Greengard, A. Aperia, and B. Meister, unpublished observations). RU3 1 (anti-PPI y) identified a protein of about 40 kDa present only in testis of all tissues examined (Fig. ll) , which likely represents the alternatively spliced, testis-specific PPly2 isoform. Table 1 compares the ex- .,,, the distribution of PPlo in rat brain \ and peripheral tissues. ACC, anterior \ cingulate cortex; Ad, adrenal gland; Cb, cerebellum; FC, frontal cortex; Hi, hippocampus; Ht, heart; Hy, hvpothalpression of PPla and PPlyl, as determined in this study, with the previously described distribution of DARPP-32 and inhibitor 1 (Hemmings et al., 1992) .
Lesion experiments
Following unilateral kainic acid lesion of the striatum, the expression of PPla and PPly 1 was investigated by immunoblotting of both ipsilateral and contralateral striatum and substantia nigra. Figure 13 shows a series of typical results and Table 2 summarizes all data. The expression of both PPlu and PPI yl was significantly reduced in the lesioned striatum, the former by 33% and the latter by 44% (Table 2) . DARPP-32, known to be enriched in the medium-sized spiny neurons of the striatum, was reduced by 53% in the same samples. In contrast, in the lesioned substantia nigra DARPP-32 levels were substantially reduced but not those of PPla and PPlyl. As expected, GFAP expression was dramatically increased following kainate lesion, whereas actin and tubulin expression remained relatively unchanged (Fig. 13 , Table 2 ), both in the striatum and in the substantia nigra.
Discussion
Identijcation of neuronal protein phosphatase I isoforms The cDNA sequence of 1404 nt for rat PPlol is shown in Figure  1 . It includes an additional 35 nucleotides of 5'-noncoding sequence compared to the sequence reported by Sasaki et al. (1990) , and extends all the way to the poly(A) tail. The deduced amino acid sequence of PPla is identical to those known from other mammalian species, including rabbit (Bai et al., 1988; Cohen, 1988 ) and human (Barker et al., 1990 ; E. E da Cruz e Silva Figure Il . Immunoblot analysis of the distribution of PPlyl in rat brain and peripheral tissues. See legend to Figure 10 for key to symbols. Figure 12 . Comparison of the relative abundance of PPlcx and PPlyl in different rat brain areas (A) and peripheral tissues (B). Immunoblots were quantitated on a phosphoimager and the results are expressed in relation to the striatum (percentage of striatum).
and P Greengard, unpublished observations). The cDNA sequence of 266% nt for rat PPlp is shown in Figure 3 . The deduced amino acid sequence of rat PPI p is identical to the mouse dis2m2 sequence (Ohkura et al., 1989) . Sasaki et al. (1990) identified a rat PPly isoform identical to the one described here (this isoform is referred to as PPI yl to differentiate it from the alternatively spliced PPly2 isoform that is thought to be expressed only in the testis). Figure 2 comprises 1.508 nt of cDNA sequence derived from PPl y I that encodes the C-terminal I 13 amino acids of the protein. It would appear that the libraries used either did not contain cDNA clones encoding the 5' portion of PPlyl, or that such clones were relatively rare. The deduced partial amino acid sequence is identical to both the rat sequence reported by Sasaki et al. (1990) and the human sequence. Indeed, the full length human and rat sequences differ only at a single residue, Ile-4 in rat (and mouse) being replaced by Leu in the human sequence (E. E da Cruz e Silva and I? Greengard, unpublished observations).
The work described here identified PPla and PPlyl in the rat striatum but failed to show the occurrence of either PPl p or any other isoforms by low stringency screening of a rat cDNA library. However, PPIP clones were isolated from a rat cortex cDNA library. Differential expression of neuronal isoforms cf PPI The distribution of PPla, PPlp, and PPlyl mRNAs in rat brain was investigated by in situ hybridization. The results indicate that the three known PPI genes are widely expressed throughout the rat brain. Broad cortical distribution of mRNA for all three isoforms was observed, but the hippocampus and cerebellum showed particularly strong hybridization for all three probes (Figs. 6, 7) . None of the PPI isoforms is uniquely expressed in the striatum, but there is a somewhat lower level of PPlp signal from this area, in contrast to PPIcx and PPlyl which were relatively more abundant (Fig. 5) . Interestingly, PPlyl appears to be uniquely expressed in the islands of Calleja (Fig. 5) isoforms in the pineal gland (Fig. 7) . Of the three PPI isoforms, only PPlp and PPI yl show significant expression in the brainstem (Fig. 8) .
The isoform-specific antibodies described here allowed an investigation of the distribution of the individual PPI isoforms to be carried out by immunoblotting. In general, PPla and PPlyl were found throughout all brain regions and peripheral tissues examined (Fig. 12, Table 1 ). However, both are relatively more abundant in neuronal tissues. Ironically, skeletal muscle was found to contain relatively modest amounts of PPI, although it is the normal source for protein purification (it is possible that PPlp may be the main isoform expressed in skeletal muscle). PPla and PPl y 1 are also present in cultured cells including rat pheochromocytoma PC12 cells (Figs. 10, 11 ) and other immortalized cell lines, including monkey kidney COS cells, mouse neuroblastoma NS20Y cells and human glioma Hs683 (data not shown). However, the highest concentrations of PPla and PPlyl were measured in the striatum (Figs. 10-12 , Table 1 ). Immunoblotting of guinea pig striatum, frontal cortex, and cerebellum yielded results virtually identical to those obtained for rat (not shown).
A comparative analysis of the results obtained by in situ hybridization and immunoblotting reveals some superficial discrepancies. The strongest hybridization signals were obtained in the hippocampus and cerebellum, whereas the strongest immunolabeling was observed in striatal homogenates. There are three possible explanations for these results, since the two techniques measure different parameters (mRNA by in situ hybridization and protein by immunoblotting). It is possible that the protein and its corresponding mRNA may be localized to different subcellular loci. The relative intensities may also reflect differences in posttranslational regulation of PPl mRNAs in the various brain areas. Alternatively, the results may be explained by the relative coarseness of the tissue dissection technique (used for immunoblotting), compared to the in situ analysis; the neuropil surrounding the highly labeled cell layers in the hippocampus and cerebellum (Figs. 6-8 ) is virtually devoid of any signal. Thus, the unlabeled tissue would be expected to reduce the signal obtained from crude dissection of these structures.
Lesion experiments. The effects of unilateral lesions of the rat striatum using kainic acid were assessed by immunoblotting of contralateral and ipsilateral striatum and substantia nigra. The levels of actin and tub&n remained relatively constant. In contrast, the levels of GFAP increased dramatically following kainic acid lesion, presumably due to the resulting gliosis. The loss of striatal neurons and their terminals was confirmed by measuring the levels of DARPP-32. A dramatic decrease in DARPP-32 was observed both in the striatum and in the substantia nigra. We found a substantial and reproducible decrease in the levels of both PPIcv and PPI y I in the Iesioned striatum. However, in the substantia nigra, the decrease for both isoforms, although reproducible, was quite small. Strong immunoreactivity for PPla and PPlyl has been observed in dendritic spines, but only weak immunoreactivity in axons and nerve terminals, at the ultrastructural level (Ouimet et al., in press ). The observed distribution at the ultrastructural level could account for the much greater decrease observed in the striatum than in the substantia nigra following striatal lesions.
In a previous study it was found that PPl activity was not affected by kainic acid lesion of the striatum (Nairn et al., 1988) . Those results can be reconciled with the present results if we bear in mind the following points. A substantial proportion of brain PPI is known to exist in an inactive form. There is also some evidence that it exists in different tissues with different specific activities. At present, no data are available comparing the abundance of different PPI isoforms and activity in different cell types, for example neuronal cells versus glia. Thus, the immunoblot results presented here are a more reliable measure of phosphatase levels.
The present lesion studies indicate that PPla and PPI y 1 are expressed within the medium size spiny neurons that project to the substantia nigra, the majority of which are also known to contain DARPP-32 and inhibitor I. If colocalized within individual neurons, PPI isoforms may be segregated into subcellular compartments or macromolecular complexes allowing specific regulation by DARPP-32 or inhibitor I, or fostering interaction with sequestered substrates. Further studies will be required to determine which isoforms of PPI are colocalized with DARPP-32 and which with inhibitor 1. 
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